Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 325 of 443 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/24/23
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 07/31/14
Due: 07/31/15
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Phase: N/A
Priority: Normal
Start: 03/16/23
End: 04/01/24
Due: 04/01/25
Phase: N/A
Priority: Normal
Start: 08/05/24
End: 02/08/25
Due: 02/08/26
Phase: N/A
Priority: Normal
Start: 04/15/23
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 02/18/13
End: 02/28/18
Due: 02/28/19
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 08/18/11
End: 08/07/17
Due: 08/07/18
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 02/28/25
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 01/03/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 02/23/17
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 07/13/22
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 01/02/14
End: 07/30/18
Due: 07/30/19
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 11/06/23
Due: 11/06/24
Phase: N/A
Priority: Normal
Start: 06/10/22
End: 12/15/22
Due: 12/15/23
Phase: N/A
Priority: Normal
Start: 01/31/25
End: 04/30/29
Due: 04/30/30
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 06/30/29
Due: 06/30/30
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 12/30/20
End: 10/31/22
Due: 10/31/23